#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Crohn's disease Bronchiectasis Pelizaeus-Merzbacher disease Netherton's syndrome B precursor type acute leukaemia Barth syndrome Non-Hodgkin's lymphoma unspecified histology indolent Ovarian cancer Desmoid tumour Hereditary angioedema Thrombocytopenia Haemophagocytic lymphohistiocytosis Tuberous sclerosis complex Acute graft versus host disease Craniocerebral injury More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Basic Information Usher’s syndrome Hepatic angiosarcoma – Basic Information Sarcoma – Life with Disease Uterine leiomyosarcoma – Basic Information Sjogren’s syndrome – Treatment Mucopolysaccharidosis II – Trials in Disease Alport’s syndrome – Life with Disease SAPHO syndrome – Life with Disease Behcet’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lovo-B Fidanacogene Elaparvovec Inclisiran Sodium Abatacept Selatogrel Nefopam Hydrochloride Omp12 LINAPRAZAN GLURATE VELPATASVIR INF904 Vincristine Hydroxypropyl Cellulose Lf Testosterone Undecanoate Lna043 Sodium Iodide (131I) Tucatinib F125/10 Infliximab ANHYDROUS CALCIUM FOLINATE Alx148 More therapies…

    Learn about Your Condition

    Type V hyperlipidaemia Lymphatic malformation Langerhans cell sarcoma Lyme disease Noninfective chorioretinitis Osteochondrodysplasia Tachypnoea Neoplasm malignant Mucopolysaccharidosis Tympanic membrane hyperaemia Drug dependence Endometrial cancer stage II Giant cell arteritis Bone marrow failure Cervix carcinoma recurrent More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny W Bialymstoku

Uniwersytecki Szpital Kliniczny W Bialymstoku

Zurawia 14, Bialystok, 15-540, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study of ABBV-400 and Budigalimab for Adults with Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Budigalimab
    • Carboplatin
    • Cisplatin
    Belgium France Germany Italy Poland Romania +1

  • Study of Optimal Treatment for Uncontrolled Hypertension Using Triple Drug Combinations (Olmesartan/Amlodipine/Hydrochlorothiazide or Perindopril/Indapamide/Amlodipine) with Additional Diuretics

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Amlodipine
    • Amlodipine Besilate
    • Eplerenone
    Poland

  • Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

    Recruiting

    3 1
    Investigated Drugs:
    • TIFCEMALIMAB
    • Toripalimab
    Belgium France Germany Italy The Netherlands Poland +2

  • Study on the Effect of Metformin on Endometrial Function in Women with Unexplained Infertility

    Recruiting

    2 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Metformin Hydrochloride
    Poland

  • Study on the Effect of Metformin on Fertility in Women with Thyroid Cancer Treated with Radioactive Iodine

    Recruiting

    3 1 1
    Investigated Drugs:
    • Metformin Hydrochloride
    Poland

  • Study of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage II
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    France Greece Hungary Poland

  • Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    Investigated Drugs:
    • Bi 690517
    • Empagliflozin
    Belgium Bulgaria Czechia Germany Hungary Italy +5

  • Study on Efepoetin Alfa and Darbepoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaemia of chronic disease
    Investigated Drugs:
    • Darbepoetin Alfa
    • Efepoetin Alfa
    Bulgaria Czechia Italy Poland Romania Slovakia

  • Study of Pembrolizumab and V940 for Treating Non-Small Cell Lung Cancer in Patients with Resectable Stage II to IIIB (N2) Not Achieving Complete Response

    Recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Gemcitabine Hydrochloride
    Belgium Bulgaria Finland France Germany Greece +8
Previous Page
1 … 3 4 5 6 7 … 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!